Feedback / Questions
ATT-01 - Attivare Therapeutics
ATT-02 - Attivare Therapeutics
https://www.businesswire.com/news/home/20250428401649/en/Attivare-Therapeutics-to-Present-Preclinical-Data-for-ATT-01-and-ATT-02-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2025
 
Apr 28, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious